Menu Back toSession-5-Summary-Protocol-and-Results-Information-EudraCT-ClinicalTrials-gov

Global Clinical Trials Transparency Conference

Session 5: Summary Protocol and Results Information: & EudraCT

Session Chair(s)

Matthias  Zerm, PhD

Matthias Zerm, PhD

  • Lead Expert, Clinical Trial Disclosure and R&D Processes
  • Merz Pharmaceuticals GmbH, Germany
Are you prepared to posting results in both registries? How do you ensure consistency across registries considering differences in data fields, process (quality review versus purely automated validation) and timing? This session will address procedural aspects, will give insights around the quality control review at and provide an outlook on how information contained in clinical trial registries may become more aligned and more meaningful for patients.


Thomas  Wicks, MBA

Managing Submissions to Global Registries

Thomas Wicks, MBA

  • Chief Strategy Officer
  • Trialscope, Inc., United States
Heather  Dobbins, PhD

Results Submission “Success”: An Update

Heather Dobbins, PhD

  • Lead Results Analyst, NCBI/NLM
  • National Institutes of Health (NIH), United States
Smita  Shukla

Improving GSK’s first time acceptance record for Results submissions on

Smita Shukla

  • Director Clinical Disclosure Reporting
  • GSK, United States
Munther  Baara, MS

Transcelerate Initiative to Improve Data Quality in Clinical Trial Registries

Munther Baara, MS

  • Head, New Clinical Paradigm
  • Pfizer Inc, United States